glp 1 dosage per week Tirzepatide Chart & Dosing Guide for Weight Loss Richard Lipman MD... - Richard

Patients who hit them stay out of the fatigue and hair-shedding spiral

Final Salon of the Season | Psychedelics & Grief | May 7th @730pm Psychedelics and Grief | Thursday, May 7, 2026 Grief is one of the most universal yet isolating experiences we endure and emerging research suggests psychedelics like psilocybin, MDMA, and 5-MeO-DMT may offer a genuine path through it

Key Findings: Large human studies across multiple countries have not found increased thyroid cancer rates in GLP-1 users The FDA warning applies to medullary thyroid carcinoma (MTC)only 3-4% of all thyroid cancers The warning exists because rodents developed C-cell tumors, but humans and rodents differ biologically Some studies show associations, but these are explained by detection bias (more monitoring = finding pre-existing nodules) The Clayman Thyroid Center (2,000+ thyroid cancer patients/year) has not seen an MTC pattern linked to GLP-1 use (or for that matter any other thyroid malignancy) Clinical Recommendations: Patients with MTC history or MEN2 should not take GLP-1 receptor agonists Patients with common thyroid cancers (papillary, follicular, Hrthle cell) should not assume GLP-1 caused them or will have an effect upon them Decisions should be individualized, weighing metabolic benefits against theoretical concerns GLP-1 therapy does not require additional thyroid monitoring Quick Reference for Clinicians Understanding the Question What Medications Are We Discussing

10.1126/science.1090278 132 SmithM